FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely celecoxib 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Celecoxib 400 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely alendronate sodium 70 milligram and colecalciferol 140 microgram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alendronate sodium 70 milligram and colecalciferol 140 microgram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely orlistat 60 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Astemizole 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Lovastatin 40 mg and nicotinic acid 1 g oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Lovastatin 40 mg and nicotinic acid 1 g oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Nicotinic acid 250 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Armodafinil 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Armodafinil 150 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Armodafinil 250 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely oseltamivir phosphate 30 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely oseltamivir phosphate 45 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Ambrisentan 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Carisoprodol 250 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Ambrisentan 5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amlodipine besilate 2.5 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely nebivolol 2.5 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely nebivolol 10 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Beclometasone dipropionate 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Alvimopan 12 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet Has presentation strength numerator value False un Inferred relationship Some 1
    Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Milnacipran hydrochloride 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Milnacipran hydrochloride 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Milnacipran hydrochloride 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Milnacipran hydrochloride 12.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely bromocriptine 800 microgram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Chenodeoxycholic acid 250 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Benzonatate 150 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Metaxalone 800 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely azilsartan medoxomil 40 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely azilsartan medoxomil 80 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely afatinib dimaleate 20 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely afatinib dimaleate 30 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely afatinib dimaleate 40 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely bosutinib monohydrate 100 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely bosutinib monohydrate 500 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Canagliflozin 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Abiraterone acetate 250 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Apixaban 2.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Apixaban 5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Avanafil 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Avanafil 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Avanafil 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Boceprevir 200 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely ceritinib 150 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1

    Start Previous Page 11 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start